Dose Delays and Treatment Interruptions Secondary to Ocular Toxicity From BCMA-Directed Antibody Drug Conjugate Therapy in Relapsed Multiple Myeloma
- DOI
- 10.1016/j.clml.2025.10.003
- Published
- 2026-02
- Container
- Clinical Lymphoma Myeloma and Leukemia
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.clml.2025.10.003,
title = {Dose Delays and Treatment Interruptions Secondary to Ocular Toxicity From BCMA-Directed Antibody Drug Conjugate Therapy in Relapsed Multiple Myeloma},
author = {Matthew J. Rees and Timothy T. Xu and Suheil Albert Atallah-Yunes and Kenneth J C Lim and Sikander Ailawadhi and Ricardo Parrondo and Rafael Fonseca and Peter Leif Bergsagel and Suzanne Hayman and Angela Dispenzieri and Francis Buadi and David Dingli and Rahma Warsame and Prashant Kapoor and Jithma P Abeykoon and Morie A. Gertz and Eli Muchtar and Taxiarchis Kourelis and Wilson Gonsalves and S. Vincent Rajkumar and Sanjay V. Patel and Shaji Kumar},
year = {2026},
journal = {Clinical Lymphoma Myeloma and Leukemia},
doi = {10.1016/j.clml.2025.10.003},
url = {https://doi.org/10.1016/j.clml.2025.10.003}
}RIS
TY - JOUR TI - Dose Delays and Treatment Interruptions Secondary to Ocular Toxicity From BCMA-Directed Antibody Drug Conjugate Therapy in Relapsed Multiple Myeloma AU - Matthew J. Rees AU - Timothy T. Xu AU - Suheil Albert Atallah-Yunes AU - Kenneth J C Lim AU - Sikander Ailawadhi AU - Ricardo Parrondo AU - Rafael Fonseca AU - Peter Leif Bergsagel AU - Suzanne Hayman AU - Angela Dispenzieri AU - Francis Buadi AU - David Dingli AU - Rahma Warsame AU - Prashant Kapoor AU - Jithma P Abeykoon AU - Morie A. Gertz AU - Eli Muchtar AU - Taxiarchis Kourelis AU - Wilson Gonsalves AU - S. Vincent Rajkumar AU - Sanjay V. Patel AU - Shaji Kumar PY - 2026 JO - Clinical Lymphoma Myeloma and Leukemia DO - 10.1016/j.clml.2025.10.003 UR - https://doi.org/10.1016/j.clml.2025.10.003 ER -
APA
Rees, M. J., Xu, T. T., Atallah-Yunes, S. A., Lim, K. J. C., Ailawadhi, S., Parrondo, R., Fonseca, R., Bergsagel, P. L., Hayman, S., Dispenzieri, A., Buadi, F., Dingli, D., Warsame, R., Kapoor, P., Abeykoon, J. P., Gertz, M. A., Muchtar, E., Kourelis, T., Gonsalves, W., Rajkumar, S. V., Patel, S. V., & Kumar, S. (2026). Dose Delays and Treatment Interruptions Secondary to Ocular Toxicity From BCMA-Directed Antibody Drug Conjugate Therapy in Relapsed Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2025.10.003
Source records
- crossref · retrieved 2026-09-27T10:45:12.347Z